Inflammation contributes to cardiovascular risk in patients receiving statin therapy
- PMID: 36893776
- DOI: 10.1016/S0140-6736(23)00454-3
Inflammation contributes to cardiovascular risk in patients receiving statin therapy
Comment on
-
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials.Lancet. 2023 Apr 15;401(10384):1293-1301. doi: 10.1016/S0140-6736(23)00215-5. Epub 2023 Mar 6. Lancet. 2023. PMID: 36893777 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
